BSF Enterprise Plc (BSFA.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 08:48AM BST. Market open.
| Previous close | 5.00 |
| Open | 4.77 |
| Bid | 4.50 x N/A |
| Ask | 5.50 x N/A |
| Day's range | 4.77 - 5.28 |
| 52-week range | 4.50 - 16.90 |
| Volume | |
| Avg. volume | 720,239 |
| Market cap | 5.724M |
| Beta (5Y monthly) | 1.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update
LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, today provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues (3DBT). 3DBT's City-MixTM is a patented non-toxic culture media supplement that acts as an effective 'cell booster'. It is
© 2024 Yahoo. All rights reserved.